2026 ICD-10-CM Diagnosis Code Q87.43Marfan syndrome with skeletal manifestation
ICD-10-CM Codes›Q00-Q99›Q80-Q89›Q87
- Billable — Valid for Submission
- POA Exempt
- Chronic Condition
Q87.43 is a billable ICD-10-CM diagnosis code for marfan syndrome with skeletal manifestation. It is valid on HIPAA claims for fiscal year 2026 (October 1, 2025 through September 30, 2026) and groups to MS-DRG 306 through 307. The code is exempt from POA reporting. Coders also document this condition as arachnodactyly. In AHRQ's Clinical Classifications Software (CCSR), this diagnosis falls under Other specified and unspecified congenital anomalies.
Code Identity
Code Classification
Present on Admission (POA)Billing
Q87.43 is exempt from POA reporting on inpatient claims to general acute care hospitals. Review other POA exempt codes.
Approximate SynonymsGuidance
Alternate terms and clinical phrases that map to this code.
- Arachnodactyly
- Congenital contractural arachnodactyly
- Congenital dolichostenomelia
- Disorder of skeletal system co-occurrent and due to Marfan syndrome
- Hypermobility syndrome
- Laxity of ligament
- Marfanoid joint hypermobility syndrome
- Marfan's syndrome
Index to Diseases and InjuriesGuidance
Alphabetical index entries that point to this code.
- Syndrome - See Also: Disease;
- with
- skeletal manifestations - Q87.43
External Cause of Injuries IndexGuidance
References for this code in the External Cause of Injuries Index.
- Syndrome
- Marfan
- with
- skeletal manifestations
Clinical ClassificationClinical
AHRQ’s CCSR groups this code into broader clinical categories.
Clinical InformationClinical
Arachnodactyly
an abnormal bone development that is characterized by extra long and slender hands and fingers, such that the clenched thumb extends beyond the ulnar side of the hand. arachnodactyly can include feet and toes. arachnodactyly has been associated with several gene mutations and syndromes.
Patient EducationClinical
Marfan Syndrome
Marfan syndrome is a disorder that affects connective tissue. Connective tissues are proteins that support skin, bones, blood vessels, and other organs. One of these proteins is fibrillin. A problem with the fibrillin gene causes Marfan syndrome.
Read the full article at MedlinePlus
Courtesy of MedlinePlus, a service of the U.S. National Library of Medicine.
Convert Q87.43 to ICD-9-CMHistory
The closest ICD-9-CM equivalents under the General Equivalence Mappings.
Code HistoryHistory
Questions About Q87.43Overview
Is Q87.43 (Marfan syndrome) a billable code?
Yes. This is a billable ICD-10-CM code, specific enough to report marfan syndrome with skeletal manifestation on HIPAA-covered claims from October 1, 2025 through September 30, 2026.
What MS-DRG does Q87.43 group to?
When marfan syndrome with skeletal manifestation is the principal diagnosis on an inpatient stay, it groups to MS-DRG 306, 307, with relative weights from 0.9132 to 1.5758 depending on complications. Higher weights mean higher Medicare reimbursement.
Is Q87.43 exempt from POA reporting?
Yes. CMS lists this code among those exempt from present on admission reporting, so hospitals do not assign a POA indicator for marfan syndrome with skeletal manifestation on inpatient claims.
What is the ICD-9 equivalent of Q87.43?
Under the General Equivalence Mappings, marfan syndrome with skeletal manifestation converts to ICD-9-CM 759.82 (marfan syndrome). The mapping is approximate, so confirm the match fits the documentation.
Footnotes
[1] Chronic - a chronic condition code indicates a condition lasting 12 months or longer and its effect on the patient based on one or both of the following criteria:
- The condition results in the need for ongoing intervention with medical products,treatment, services, and special equipment
- The condition places limitations on self-care, independent living, and social interactions.
